Home NDC 68382-125
acyclovir
Product NDC 68382-125
11-digit product format 683820125
Labeler code 68382
Product ID 68382-125_0ff593fa-7941-4ca2-a780-120a96b7217a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACYCLOVIR
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Zydus Pharmaceuticals USA Inc.
Application ANDA206606
Marketing category ANDA
Marketing start 2017-08-17
Marketing end 0000-00-00
Substance ACYCLOVIR SODIUM
Active strength 500 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68382-125 ACYCLOVIR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ZYDUS PHARMACEUTICALS USA INC.] 4 Legacy NDC 20221118_ca54c058-808e-4ad2-a33e-07796a4b27d4.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 68382-125-10 68382012510 10 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68382-125-10) 2017-08-17 0000-00-00 No No Current